Tesamorelin stands out with a robust clinical corpus including pivotal phase 3 trials on over 800 patients (HIV lipodystrophy indication), with 52-week data documenting a significant reduction in visceral fat (visceral adipose tissue, VAT) and improved lipid parameters
Pregnant women are recommended folic acid supplementation
The only difference is the syringe math: each dose delivers all four peptides in a fixed ratio
*Correspondence: Gad Elsayed Mohamed Salem, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
But not without limitations
The Statistics: Who Is Using These Medications 1 in 8 Americans reported using a GLP-1 medication as of 2025 (Gallup National Health and Well-Being Index, 2025) 12.4% of Americans reported GLP-1 use in late 2025 more than double the 5.8% reported in February 2024 40 million+ GLP-1 prescriptions were written in the United States in 2024 alone Approximately 63% of patients who began Wegovy or Zepbound in early 2024 remained on therapy one year later, up from 40% among the 2023 cohort